Palisade Bio (PALI) Current Assets (2010 - 2026)

Palisade Bio (PALI) has 17 years of Current Assets data on file, last reported at $133.2 million in Q1 2026.

• Current Assets for Q1 2026 came in at $133.2 million, up 1589.4% year-over-year; the trailing twelve-month figure through Mar 2026 was $133.2 million (up 1589.4% YoY), and the FY2025 annual result was $134.2 million, up 1179.03% from the prior year.
• Current Assets slipped to $133.2 million in Q1 2026 per PALI's latest filing, from $134.2 million in the prior quarter.
• Over five years, Current Assets peaked at $134.2 million in Q4 2025 and troughed at $6.4 million in Q2 2025.
• A 5-year average of $25.8 million and a median of $12.3 million in 2024 frame the typical range for Current Assets.
• The sharpest annual moves came in 2022 and 2026: Current Assets plunged 49.64% in 2022, then jumped 1589.4% in 2026.
• A 5-year view of Current Assets shows it stood at $14.7 million in 2022, then dropped by 9.54% to $13.3 million in 2023, then fell by 21.26% to $10.5 million in 2024, then soared by 1179.03% to $134.2 million in 2025, then declined by 0.73% to $133.2 million in 2026.
• Business Quant data shows PALI's Current Assets at $133.2 million in Q1 2026, $134.2 million in Q4 2025, and $6.8 million in Q3 2025.